If you enjoy this content, please share it with a colleague
RELATED CONTENT
For high-risk patients who receive chemoradiation therapy for head and neck cancer, frequent follow-up appointments conducted by advance practice nurses (APN) in a clinical outpatient setting allowed for more intensive symptom management. This program resulted in fewer post-treatment emergency room visits and hospital admissions compared to historical outcomes, according to research presented at the American Society for Radiation Oncology’s (ASTRO’s) 57th annual meeting.
October 20, 2015 — For cervical cancer patients undergoing postsurgical radiation therapy, image-guided intensity ...
Immunotherapy combined with palliative radiation therapy (RT) for a subset of patients with metastatic melanoma reduces the growth and spread of the cancer, according to research presented at the American Society for Radiation Oncology’s (ASTRO’s) 57th annual meeting.
For some early-stage breast cancer patients, accelerated partial breast irradiation (APBI) using multicatheter brachytherapy following breast conserving surgery may be an excellent treatment option. In new research presented at the American Society for Radiation Oncology’s (ASTRO’s) 57th annual meeting, APBI was proven to be as effective as the current standard treatment – whole breast irradiation (WBI) – in local control, disease-free and overall survival rates.
For some patients with human papilloma virus (HPV)-related cancer of the tonsils and tongue, reduced intensity radiation therapy (RT) and chemotherapy may be as effective as standard-dose radiation and chemotherapy, and result in less acute side effects. This conclusion came from research presented at the American Society for Radiation Oncology’s (ASTRO’s) 57th annual meeting, Oct. 18-21 in San Antonio.
A prospective study of guideline-based postoperative image-guided intensity modulated radiation therapy (IG-IMRT) in prostate cancer patients found toxicity profiles low and patient-reported quality of life following treatment favorable. Researchers concluded that toxicity and health-related quality of life (HRQOL) should not impact the recommendation of radiation therapy treatment following prostatectomy.
October 2, 2015 — The American Society for Radiation Oncology (ASTRO) applauded the members of Congress who signed ...
The American Society for Radiation Oncology’s (ASTRO’s) 57th annual meeting will be held at the Henry B. González Convention Center, Oct.18-21, 2015, in San Antonio.
The American Society for Radiation Oncology (ASTRO) has selected seven leading physician-researchers to receive a total ...
The American Society of Radiation Oncology (ASTRO) has raised concerns about proposed additional payment cuts to radiation therapy in the proposed Medicare Physician Fee Schedule (MPFS) for 2016, released July 8, 2015. All changes would take effect on Jan. 1, 2016.